Advertisement

Topics

Pfizer Gets FDA Approval For Rare Blood Cancer Drug Besponsa

21:35 EDT 17 Aug 2017 | FinanzNachrichten

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) said that the U.S. Food and Drug Administration has approved Besponsa(inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-c...

Original Article: Pfizer Gets FDA Approval For Rare Blood Cancer Drug Besponsa

NEXT ARTICLE

More From BioPortfolio on "Pfizer Gets FDA Approval For Rare Blood Cancer Drug Besponsa"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...